{
    "code": "02022924",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02022924",
    "time": "2019-08-16 03:03:40",
    "許可證字號": "衛署藥輸字第022924號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "109\/06\/20",
    "發證日期": "89\/06\/20",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202292400",
    "中文品名": "內舒拿水溶性鼻用噴液劑",
    "英文品名": "NASONEX AQUEOUS NASAL SPRAY",
    "適應症": "成人青少年及二歲以上兒童之季節性或常年性過敏性鼻炎。亦用於治療18歲及以上成人輕度到中度鼻息肉之相關症狀。",
    "劑型": "404鼻用噴液劑",
    "包裝": "50MCG\/SPRAY,100公撮以下瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": "MOMETASONE FUROATE MONOHYDRATE MICRONIZED EQ TO MOMETASONE FUROATE ANHYDROUS",
    "主製造廠": {
        "申請商名稱": "0929301100  美商默沙東藥廠股份有限公司台灣分公司",
        "申請商地址": "台北市信義區信義路五段106號12樓",
        "主製造廠": "",
        "製造廠名稱": "FBE0006000  SCHERING-PLOUGH LABO N.V."
    },
    "CCC號列": "30043200002 其他醫藥製劑，含有腎上腺皮質類固醇荷爾蒙及其衍生物或結構式類似者Other medicaments, containing corticosteroid hormones, their derivatives or structural analogues",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6804002330",
            "成分名稱": "MOMETASONE FUROATE MONOHYDRATE MICRONIZED EQ TO MOMETASONE FUROATE ANHYDROUS",
            "含量描述": "",
            "含量": "0.0500000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "20170920_QRD_NASONEX_Chi_CCDS052017_clean-106-09-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022924&Seq=014&Type=9"
        },
        {
            "title": "Nasonex Aqueous Nasal Spray Label-104-08-21(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022924&Seq=008&Type=8"
        }
    ]
}